Comprehensive analysis of therapy-relevant genome alterations for individualized cancer therapy
Non-invasive blood test for molecular cancer diagnostics
Cancer is a disease of the genome and can be treated individually with targeted therapies. Our NEOplus test is capable of identifying the specific genome alterations responsible for each cancer type. This enables the treating physician to select the most suitable targeted therapy for the patient.
We take care of the entire analytical process. Our team includes some of the most renowned German cancer researchers. With their expertise they advise doctors on individualized cancer therapies with targeted drugs.
A single sample from the patient is sufficient for the analysis. We guarantee a comprehensive test report within 10-15 working days, allowing the physician to treat the patient in the most time efficient manner.
The founding and management team of New Oncology.
Comprehensive molecular genetic diagnostics with NEOplus.
Frequently asked questions.
Current press releases, talks and reports.
Back to the top